SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-058172
Filing Date
2023-11-02
Accepted
2023-11-02 16:05:22
Documents
14
Period of Report
2023-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20231102.htm   iXBRL 8-K 42775
2 EX-99.1 cytk-ex99_1.htm EX-99.1 268535
3 GRAPHIC img114956760_0.jpg GRAPHIC 7836
  Complete submission text file 0000950170-23-058172.txt   455345

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cytk-20231102_lab.xml EX-101.LAB 13474
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cytk-20231102.xsd EX-101.SCH 2469
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cytk-20231102_pre.xml EX-101.PRE 9900
8 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20231102_htm.xml XML 4753
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 231372176
SIC: 2834 Pharmaceutical Preparations